Kidney Care Community Commends Lawmakers for Adding Critical

“KidneyX” Funding in Proposed House FY 2020 Appropriations Bill to Address

Nation’s Kidney Disease Epidemic

Inclusion of $10 Million in Federal Funding Will Complement $25 Million in Private Sector
Investment for Kidney Disease Research and Innovation.

Washington, DC, May 02, 2019 --(PR.com)-- Kidney Care Partners (KCP) - the nation's leading kidney
care multi-stakeholder coalition representing patient advocates, physician organizations, health
professional groups, dialysis providers, researchers and manufacturers - today commended lawmakers on
the House Appropriations Committee for including $10 million in federal funding to support the KidneyX
prize, a joint public-private partnership to accelerate innovation in the prevention, diagnosis, and
treatment of kidney disease and kidney failure, requiring dialysis.

An estimated 40 million American adults are currently living with chronic kidney diseases, which, if left
untreated, can ultimately progress to kidney failure, requiring dialysis care or a kidney transplant.
Furthermore, millions more individuals are at risk of developing these potentially deadly diseases and are
not aware of their risk.

Last month, a group of 58 lawmakers from both parties led by Representatives Suzan DelBene (D-WA),
Brian Babin (R-TX), Terri Sewell (D-AL) and Larry Bucshon (R-IN) signed a letter urging their
colleagues on the House Appropriations Committee to support KidneyX and allocate funding for it in the
Fiscal Year 2020 Labor, Health and Human Services, Education, and Related Agencies appropriations
bill. Such funding was included in the draft unveiled this week.

“This funding for KidneyX is an important step toward addressing existing barriers to innovation in
kidney care and ensuring patients have access to the most advanced and innovative treatments,” said Dr.
Allen Nissenson, chair of KCP. “KCP applauds Representatives DelBene, Babin, Sewell, and Bucshon
for supporting innovative approaches to kidney disease management so Americans living with kidney
diseases can continue to get the best care, access, and choice there is.”

KidneyX was first announced in 2018 as a joint public-private partnership between the Department of
Health and Human Services (HHS) and the American Society of Nephrology (ASN) to spur the
development and commercialization of innovative technologies and therapeutics in the prevention,
diagnosis, and treatment of kidney diseases. Its first prize competition, Redesign Dialysis, aims to
incentivize the development of next-generation dialysis products and is about to enter Phase 2, in which
participants will be asked to develop and demonstrate prototype dialysis technologies. As a true
public-private partnership, the private sector has already contributed $25 million to fund the program and
is committed to matching federal funding to achieve a total of $250 million over the next five years.

“KidneyX fills a critical gap in the development of new kidney disease treatments and technologies and
has the potential to make a lasting difference in millions of people's lives,” concluded Dr. Nissenson. “We
are proud to see that promise continue today and thank all of our partners in the federal government,

Page 1/3
PR.com Press Release Distribution Terms of Use
Congress, and the private sector for making this a promise a reality.”

About Kidney Care Partners

Kidney Care Partners (KCP) is a coalition of more than 30 organizations, comprised of patient advocates,
dialysis professionals, care providers, researchers, and manufacturers, dedicated to working together to
improve quality of care for individuals with Chronic Kidney Disease (CKD).

Page 2/3
PR.com Press Release Distribution Terms of Use
Contact Information:
Kidney Care Partners
Sarah Ann Rhoades
703-548-0019
Contact via Email
http://www.kidneycarepartners.org/

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/784122

Page 3/3
PR.com Press Release Distribution Terms of Use